The program is designed to raise awareness about the dangers of sharing medications as well as the risks of fake or counterfeit pills purchased over social media or other unknown sources, and work with pharmaceutical and medical communities on the risks of overprescribing. Whether addressed at the state level or by an informed community-based organization, the SPF Rx program will raise community awareness and bring prescription substance misuse prevention activities and education to schools, communities, parents, prescribers, and their patients. In addition, grant recipients will be required to track reductions in opioid related overdoses and incorporate relevant prescription and overdose data into strategic planning and future programming.
Eligibility
Eligible applicants are domestic public and private non-profit entities.
Award Information
Funding Mechanism: Grant
Anticipated Total Available Funding: $3,000,000
Anticipated Number of Awards: 6
Anticipated Award Amount: Up to $500,000 per year per award
Length of Project: Up to 5 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $500,000 in total costs (direct and indirect) in any year of the proposed project. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.)
Contact Information
Program Issues
Matthew Clune
Center for Substance Abuse Prevention
Substance Abuse and Mental Health Services Administration
(240) 276-1242
dtpspfrx@samhsa.hhs.gov
Grants Management and Budget Issues
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
(240) 276-1400
OACSAP@samhsa.hhs.gov
